Viewing SEC Facts Units
Company Name:
Stoke Therapeutics, Inc.
CIK:
1623526
Start Filing Date:
2022-01-01
End Filing Date:
2022-03-31
ACCN:
0001564590-22-019268
Value:
$ 3,000,000
Value Error:
$ None
Created By:
Date Filed:
2022-05-10
FY:
2022
Fiscal Period:
Q1
Frame:
CY2022Q1I
Type:
us-gaap
Form:
10-Q
Units:
USD